Please Share:: India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
http://www.kotaksecurities.com/pdf/indiadaily/indiadaily17022012.pdf
Results
GlaxoSmithkline Pharmaceuticals: Lower margin leads to PAT miss
Results, Change in Reco
Voltas: Upgrade on cash flows, inflows and recovery even as challenges remain
Strategy
Strategy: Another ho-hum quarter; expectations of earnings upgrade cycle
premature
Visit http://indiaer.blogspot.com/ for complete details �� ��
http://www.kotaksecurities.com/pdf/indiadaily/indiadaily17022012.pdf
Results
GlaxoSmithkline Pharmaceuticals: Lower margin leads to PAT miss
Results, Change in Reco
Voltas: Upgrade on cash flows, inflows and recovery even as challenges remain
Strategy
Strategy: Another ho-hum quarter; expectations of earnings upgrade cycle
premature
No comments:
Post a Comment